Bulk RNAseq of dopaminergic neurons in vitro cultures

By Raquel Garza, PhD, Arun Thiruvalluvan, PhD, Agnete Kirkeby, PhD and Johan Jakobsson, PhD
View Published Dataset

Output Details

Description
This dataset includes bulk RNAseq (2 x 150bps reads; Illumina TruSeq Stranded mRNA library prep kit with poly-A selection) of differentiated human embryonic stem cells into dopaminergic neurons. Briefly, hES (RC17) and hiPSCs (KOLF2.1) were differentiated towards ventral midbrain (vMB) fate based on a previously published protocol (Nolbrant et al, 2017). Detailed protocols for generation of human ventral midbrain dopaminergic progenitors and dopaminergic neurons can be found at dx.doi.org/10.17504/protocols.io.kxygx4eqol8j/v1 and dx.doi.org/10.17504/protocols.io.q26g7nbd1lwz/v1, respectively.
Identifier (DOI)
10.5281/zenodo.17149267
Tags
  • Dopaminergic neurons
  • Human
  • Immune response
  • In Vitro
  • non-iPSC cell
  • RNA bulk
Team
Team Jakobsson
Program
Collaborative Research Network
Theme
Neuro-Immune Interactions

Meet the Authors

Related Research

Activation of transposable elements is linked to a region- and cell-type-specific interferon response in Parkinson’s disease

Study explores transposable elements role in Parkinson's disease neuroinflammation. TE activation in specific brain regions correlates with innate immune responses, indicating potential involvement in chronic neuroinflammation and PD progression.

View Article

Anxa1-P2A-Cre Mouse line

Anxa1-Cre knock-in mice express cre recombinase from the mouse Anxa1 promoter in Anxa1-expressing cells and subtypes of dopaminergic neurons. This strain is useful in studies of motor neuron deficits in Parkinson's disease.

View Lab Material

A molecular atlas of cell-type specific signatures in the parkinsonian striatum

Progressive dopamine loss in PD affects striatum cells differently. Transcriptomic analysis in mouse and human models reveals changes in neuronal and glial populations, highlighting resilient and vulnerable cell types for potential new treatments.

View Article
View More Outputs
Aligning Science Across Parkinson's
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.